REQUEST A DEMO
Total
USD $0.00
Search more companies

Acino - Pharma Ecuador S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Acino - Pharma Ecuador S.A. Profile Updated: February 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Acino - Pharma Ecuador S.A. is a company in Ecuador, with a head office in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on October 25, 2016. The total number of employees is currently 22 (2024). In its most recent financial highlights, the company reported a net sales revenue increase of 20.55% in 2024. Its’ total assets recorded a negative growth of 6.52%. The net profit margin of Acino - Pharma Ecuador S.A. decreased by 1.3% in 2024.

Headquarters
Av. de los Shyris N34-152, Shyris Center Bldg. , Floor 1401
Quito; Pichincha;

Contact Details: Purchase the Acino - Pharma Ecuador S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Acino - Pharma Ecuador S.A. report to view the information.
Registered Capital:
Purchase the Acino - Pharma Ecuador S.A. report to view the information.
Financial Auditors:
Purchase the Acino - Pharma Ecuador S.A. report to view the information.
Incorporation Date:
October 25, 2016
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.92%
Purchase this report to view the information.
0.08%
Company Performance
Financial values in the chart are available after Acino - Pharma Ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
20.55%
Total operating revenue
18.69%
Operating profit (EBIT)
2.15%
EBITDA
18.73%
Net Profit (Loss) for the Period
-43.57%
Total Assets
-6.52%
Total Equity
-4.39%
Operating Profit Margin (ROS)
-0.58%
Net Profit Margin
-1.3%
Return on Equity (ROE)
-5.69%
Debt/Equity
18.21%
Quick Ratio
0.01%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?